5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
Oxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the control of this neuropathy is difficult. This study was designed to investigate whether prophylactic repetitive administration of 5-HT1A receptor agonists inhibits oxaliplatin-induced mechanical allodynia in mice....
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-08-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861316300901 |
id |
doaj-b04d92f98c254652969c07d3f1d8acff |
---|---|
record_format |
Article |
spelling |
doaj-b04d92f98c254652969c07d3f1d8acff2020-11-24T21:32:00ZengElsevierJournal of Pharmacological Sciences1347-86132016-08-01131428428710.1016/j.jphs.2016.07.0085-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated miceTsugunobu Andoh0Ayumi Sakamoto1Yasushi Kuraishi2Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, JapanDepartment of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, JapanResearch Administration Division, Tokyo Medical and Dental University, Tokyo 113-8510, JapanOxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the control of this neuropathy is difficult. This study was designed to investigate whether prophylactic repetitive administration of 5-HT1A receptor agonists inhibits oxaliplatin-induced mechanical allodynia in mice. Repetitive administration of 5-HT1A receptor agonists (xaliproden and tandospirone) inhibited mechanical allodynia induced by a single intraperitoneal injection of oxaliplatin. These agonists also inhibited oxaliplatin-induced mast cell migration, which is involved in the induction of mechanical allodynia. These results suggest that the prophylactic repetitive administration of 5-HT1A receptor agonists attenuates oxaliplatin-induced mechanical allodynia by inhibiting the cutaneous mast cell migration.http://www.sciencedirect.com/science/article/pii/S1347861316300901XaliprodenTandospironeMast cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tsugunobu Andoh Ayumi Sakamoto Yasushi Kuraishi |
spellingShingle |
Tsugunobu Andoh Ayumi Sakamoto Yasushi Kuraishi 5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice Journal of Pharmacological Sciences Xaliproden Tandospirone Mast cells |
author_facet |
Tsugunobu Andoh Ayumi Sakamoto Yasushi Kuraishi |
author_sort |
Tsugunobu Andoh |
title |
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice |
title_short |
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice |
title_full |
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice |
title_fullStr |
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice |
title_full_unstemmed |
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice |
title_sort |
5-ht1a receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice |
publisher |
Elsevier |
series |
Journal of Pharmacological Sciences |
issn |
1347-8613 |
publishDate |
2016-08-01 |
description |
Oxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the control of this neuropathy is difficult. This study was designed to investigate whether prophylactic repetitive administration of 5-HT1A receptor agonists inhibits oxaliplatin-induced mechanical allodynia in mice. Repetitive administration of 5-HT1A receptor agonists (xaliproden and tandospirone) inhibited mechanical allodynia induced by a single intraperitoneal injection of oxaliplatin. These agonists also inhibited oxaliplatin-induced mast cell migration, which is involved in the induction of mechanical allodynia. These results suggest that the prophylactic repetitive administration of 5-HT1A receptor agonists attenuates oxaliplatin-induced mechanical allodynia by inhibiting the cutaneous mast cell migration. |
topic |
Xaliproden Tandospirone Mast cells |
url |
http://www.sciencedirect.com/science/article/pii/S1347861316300901 |
work_keys_str_mv |
AT tsugunobuandoh 5ht1areceptoragonistsxaliprodenandtandospironeinhibittheincreaseinthenumberofcutaneousmastcellsinvolvedintheexacerbationofmechanicalallodyniainoxaliplatintreatedmice AT ayumisakamoto 5ht1areceptoragonistsxaliprodenandtandospironeinhibittheincreaseinthenumberofcutaneousmastcellsinvolvedintheexacerbationofmechanicalallodyniainoxaliplatintreatedmice AT yasushikuraishi 5ht1areceptoragonistsxaliprodenandtandospironeinhibittheincreaseinthenumberofcutaneousmastcellsinvolvedintheexacerbationofmechanicalallodyniainoxaliplatintreatedmice |
_version_ |
1725958945737015296 |